v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net loss $ (6,072,934) $ (5,563,847)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 452,005 100,805
Stock-based compensation expense 755,594 514,313
Changes in operating assets and liabilities:    
Accounts and other receivables (515,494) 71,840
Inventory (6,879) (4,368)
Prepaid expenses and other assets (122,626) 152,768
Accounts payable 178,148 406,836
Accrued expenses (245,559) (144,013)
Unearned revenue (8,654) 38,250
Operating lease right-of-use asset (1,235) 5,913
Net cash used in operating activities (5,587,634) (4,421,503)
Cash flows from investing activities    
Purchase of property and equipment (79,082) (36,344)
Acquisition of subsidiary, net cash acquired (2,186,497)
Net cash used in by investing activities (79,082) (2,222,841)
Cash flows from financing activities    
Proceeds from issuance of Common Stock from direct offering, net of underwriting discounts, commissions, and offering expenses of $785,167 2,164,833
Proceeds from exercised stock options 74,899
Proceeds from exercise of warrants 1,343,377
Payment on loans payable (251,746)
Proceeds from loans payable 288,760
Principal repayments on finance leases (270,143) (8,433)
Net cash provided by (used in) financing activities 3,601,726 (260,179)
Net decrease in cash and cash equivalents (2,064,990) (6,904,523)
Cash and cash equivalents at beginning of period 2,821,570 11,413,759
Cash and cash equivalents at end of period 756,580 4,509,236
Supplemental disclosures of cash flow information:    
Interest expense paid in cash 13,541 11,801
Income taxes paid in cash $ 11,650 $ 18,700

Source